US Army Medical Research Institute of Infectious Diseases

NEW YORK (GenomeWeb) – Swiss-based pathogen sequencing analysis firm BioInnovation Solutions today said that it and the US Army Medical Research Institute of Infectious Diseases have developed a panel for the rapid detection and surveillance of filoviruses, such as Ebola and Marburg.

The agreement provides Akonni access to nucleic acid sequences, primers, and probes for several important biothreat agents, which it will incorporate into molecular tests on its TruArray and TruSentry platforms.

Akonni plans to use the content to develop products to expand its market presence beyond detection of infectious diseases, including global biosecurity.

The startup will use its using next-generation sequencing-based technology for applications aimed at identifying biothreats.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.